BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 19173189)

  • 1. [Role of C-C chemokines in the determination of pleural effusion etiology].
    Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
    Pneumonol Alergol Pol; 2008; 76(6):415-20. PubMed ID: 19173189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of c-c chemokines in the determination of pleural effusion etiology].
    Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
    Wiad Lek; 2008; 61(7-9):190-4. PubMed ID: 19172830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [VEGF (vascular endothelial growth factor) concentration in serum and pleural fluid of patients with pleural malignancy and pleural tuberculosis].
    Ziora D; Sielska-Spytek E; Dworniczak S; Oklek K; Kozielski J
    Pneumonol Alergol Pol; 2002; 70(9-10):458-67. PubMed ID: 12710098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cholinesterase to differentiate pleural exudates and transudates.
    Sharma M; Gupta KB; Goyal KM; Nand N
    J Assoc Physicians India; 2004 May; 52():387-90. PubMed ID: 15656028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of cholesterol in pleural effusions.
    Ram KN; Sing RS
    J Assoc Physicians India; 1995 Nov; 43(11):748-50. PubMed ID: 8773031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pleural fluid interferon-gamma (IFN-gamma) measurement as a diagnostic tool in tuberculous pleurisy].
    Krenke R; Safianowska A; Paplińska M; Korczyński P; Dmowska-Sobstyl B; Bogacka-Zatorska E; Jaworski A; Chazan R
    Pneumonol Alergol Pol; 2008; 76(4):237-45. PubMed ID: 18785128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion.
    Chan MC; Chang KM; Chao WC; Lin LY; Kuo BI; Hsu JY; Wu CL
    Respirology; 2007 May; 12(3):333-8. PubMed ID: 17539835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and pleural fluid N-Terminal-Pro-B-Type natriuretic peptide concentrations in the differential diagnosis of pleural effusions.
    Yorgancıoğlu A; Ozgen Alpaydın A; Yaman N; Taneli F; Bayturan O; Sakar Coşkun A; Celik P
    Tuberk Toraks; 2011; 59(1):1-7. PubMed ID: 21554224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of adenosine deaminase activity and its isoenzymes for diagnosis of pleural effusions.
    Gorguner M; Cerci M; Gorguner I
    Respirology; 2000 Dec; 5(4):321-4. PubMed ID: 11192541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of soluble B7-H4 in malignant pleural effusion].
    Xu CH; Yu LK
    Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(2):117-8. PubMed ID: 22490695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of pleural fluid NT-pro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions.
    Han CH; Choi JE; Chung JH
    Intern Med; 2008; 47(19):1669-74. PubMed ID: 18827414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential diagnosis between exudate and transudate in pleural effusion].
    Vázquez F; Michelángelo H; Trevisani H; González F; de Quiros B
    Medicina (B Aires); 1996; 56(3):223-30. PubMed ID: 9035477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleural fluid amino-terminal brain natriuretic peptide in patients with pleural effusions.
    Cincin A; Abul Y; Ozben B; Tanrikulu A; Topaloglu N; Ozgul G; Karakurt S; Oktay A
    Respir Care; 2013 Feb; 58(2):313-9. PubMed ID: 22710710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemia modified albumin in the differential diagnosis of pleural effusions.
    Dikensoy O; Celik N; Kul S; Gogebakan B; Bayram H; Light RW
    Respir Med; 2011 Nov; 105(11):1712-7. PubMed ID: 21843931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.
    Castaño Vidriales JL; Amores Antequera C
    Eur J Med; 1992; 1(4):201-7. PubMed ID: 1341445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of pleural viscosity in the differential diagnosis of exudative pleural effusion.
    Yetkin O; Tek I; Yetkin F; Numanoglu N
    Respirology; 2007 Mar; 12(2):267-71. PubMed ID: 17298461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema.
    Bishara J; Goldberg E; Ashkenazi S; Yuhas Y; Samra Z; Saute M; Shaked H
    Ann Thorac Surg; 2009 Jan; 87(1):251-4. PubMed ID: 19101307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
    Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
    Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.
    Fiorelli A; Vicidomini G; Di Domenico M; Napolitano F; Messina G; Morgillo F; Ciardiello F; Santini M
    Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):420-4. PubMed ID: 21172937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.